We get a mention:

"But a major part of Pfizer's strategy is to focus on its core pharma business and grow through acquisition. For instance, Pfizer bought NextWave Pharmaceuticals late last month, with its Quillivant XR medication to fight ADHD having received FDA approval earlier this year. Fool health care analyst Max Macaluso believes Pfizer should make a strategic partnership with MannKind to help it bring its inhalable insulin drug to market, despite former failures in the insulin industry. Pfizer also hopes its blood thinner, Eliquis, which it developed with Bristol-Myers Squibb , will finally gain FDA approval after getting clearance for sale in Europe last month."

http://www.dailyfinance.com/2012/12/19/will-pfizer-rise-higher-in/